Promoting cardiovascular and cerebrovascular health

Stroke

Volumn 41, Issue 6, 2010, Pages 1079-1083

  Fuster, Valentin ^a   Bansilal, Sameer ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Atrial fibrillation; Cardiovascular health; Cerebrovascular health; Education; Imaging; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN; TICAGRELOR; WARFARIN;

ALZHEIMER DISEASE; ATHEROSCLEROTIC PLAQUE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG MEGADOSE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; GASTROINTESTINAL HEMORRHAGE; HEALTH PROMOTION; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PRIMARY PREVENTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; STROKE;

CARDIOVASCULAR DISEASES; HUMANS; UNITED STATES;

EID: 77953160659     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.587709     Document Type: Review

References (24)

1. Fuster V, Mearns B. The CVD paradox: mortality versus prevalence. Nat Rev Cardiol. 2009;6:669.
2. Sanz J, Moreno PR, Fuster VJ. The year in atherothrombosis. Am Coll Cardiol. 2009;53:1326-1337.
3. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: Part I: evolving concepts. J Am Coll Cardiol. 2005;46:937-954.
4. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320-2328.
5. Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, Pasterkamp G. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol. 2009;29:128-133.
6. Muntendam P, McCall C, Sanz J, Falk E, Fuster V. The BioImagge Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. Study design and objectives. Am Heart J. 2010; in press.
7. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S III, Domanski M, McKinlay S, Fuster V. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008;155:215-223.
8. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849-1846.
9. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagu-lation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903-1912.
10. ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066-2067.
11. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361: 1139-1151.
12. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
13. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534-542.
14. Brott TG, Roubin G, Howard G, et al. The Randomized Carotid Revas-cularization Endarterectomy vs Stenting Trial (CREST): primary results. American Stroke Association International Stroke Conference 2010; February 26, 2010; San Antonio, TX. Abstract 197.
15. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
16. Brown MM, Ederle J, Bonati LH, et al. Safety results of the International Carotid Stenting Study (ICSS): early outcome of patients randomised between carotid stenting and endarterectomy for symptomatic carotid stenosis. European Stroke Conference 2009; May 27, 2009; Stockholm, Sweden. Large clinical-trials session abstract 3.
17. Meier B. Catheter-based closure of the patent foramen ovale. Circulation. 2009;120:1837-1841.
18. Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med. 2010;77:82-102.
19. Black S, Iadecola C. Vascular cognitive impairment: small vessels, big toll: introduction. Stroke. 2009;40(3 Suppl):S38-S39.
20. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010; 362:329-344.
21. Hachinski V. Shifts in thinking about dementia. J Am Med Assoc. 2008; 300:2172-2173.
22. Fuster V, Kelly B, eds. Promoting cardiovascular health in the developing world a critical challenge to achieve global health committee on preventing the global epidemic of cardiovascular disease: meeting the challenges in developing countries. Report from the Institute of Medicine of the National Academies. Washington, DC: National Academies Press; 2010.
23. Vedanthan R, Fuster V. Disease prevention: the moving target of global cardiovascular health. Nat Rev Cardiol. 2009;6:327-328.
24. Fuster V, Voute J, Hunn M, Smith SC Jr. Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern. Circulation. 2007;116:1966-1967.